Pascual-Figal D, Nunez Villota J, Perez-Martinez MT, Gonzalez-Juanatey JR, Taibo-Urquia M, Llacer Iborra P, Gonzalez-Martin J, Villar S, Soler M, Mirabet S, Aimo A, Riquelme-Perez A, Anguita Sanchez M, Martinez-Selles M, Sanchez PL, Ibanez B, Bayes-Genis A; on behalf of the COLICA Investigators (see Appendix). Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA). Eur J Heart Fail. 2024 Jun 4. doi: 10.1002/ejhf.3300. Online ahead of print. PubMed PMID: 38837516.
AÑO: 2024; IF: 16.9
|
Pascual-Figal D, Nunez J, Perez-Martinez MT, Gonzalez-Juanatey JR, Taibo-Urquia M, Llacer Iborra P, Delgado J, Villar S, Mirabet S, Aimo A, Riquelme-Perez A, Anguita Sanchez M, Martinez-Selles M, Noguera-Velasco JA, Ibanez B, Bayes-Genis A; COLICA investigators. Colchicine in acutely decompensated heart failure: the COLICA trial. Eur Heart J. 2024 Aug 30:ehae538. doi: 10.1093/eurheartj/ehae538. Online ahead of print. PubMed PMID: 39211951.
AÑO: 2024; IF: 37.6
|
Arnaldos-Carrillo M, Noguera-Velasco JA, Martinez-Ardil IM, Riquelme-Perez A, Cebreiros-Lopez I, Hernandez-Vicente A, Ros-Lucas JA, Khan A, Bayes-Genis A, Pascual-Figal D. Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19. Med Clin (Barc). 2023 Sep 8;161(5):185-191. doi: 10.1016/j.medcli.2023.04.005. Epub 2023 Apr 11. PubMed PMID: 37137804; PubMed Central PMCID: PMC10086099.
AÑO: 2023; IF: 2.6
|
Pascual-Figal DA, Zamorano JL, Domingo M, Morillas H, Nunez J, Cobo Marcos M, Riquelme-Perez A, Teis A, Santas E, Caro-Martinez C, Pinilla JM, Rodriguez-Palomares JF, Dobarro D, Restrepo-Cordoba MA, Gonzalez-Juanatey JR, Bayes Genis A; DAPA-MODA Study Investigators. Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study. Eur J Heart Fail. 2023 Aug;25(8):1352-1360. doi: 10.1002/ejhf.2884. Epub 2023 Jun 7. PubMed PMID: 37211950.
AÑO: 2023; IF: 16.9
|